Bristol-Myers Squibb Company
4-hydroxy-3-sulfonylpyridin-2(1H)-ones as APJ receptor agonists
Last updated:
Abstract:
The present invention provides compounds of Formula (I) wherein all variables are as defined in the specification, and compositions comprising any of such novel compounds. These compounds are APJ agonists which may be used as medicaments. ##STR00001##
Status:
Grant
Type:
Utility
Filling date:
14 Jun 2017
Issue date:
12 Jan 2021